Lifeboat Foundation

Quantum computers, which harness the strange probabilities of quantum mechanics, may prove revolutionary. They have the potential to achieve an exponential speedup over their classical counterparts, at least when it comes to solving some problems. But for now, these computers are still in their infancy, useful for only a few applications, just as the first digital computers were in the 1940s. So isn’t a book about the communications network that will link quantum computers — the quantum internet — more than a little ahead of itself?

Surprisingly, no. As theoretical physicist Jonathan Dowling makes clear in Schrödinger’s Web, early versions of the quantum internet are here already — for example, quantum communication has been taking place between Beijing and Shanghai via fiber-optic cables since 2016 — and more are coming fast. So now is the perfect time to read up.

Dowling, who helped found the U.S. government’s quantum computing program in the 1990s, is the perfect guide. Armed with a seemingly endless supply of outrageous anecdotes, memorable analogies, puns and quips, he makes the thorny theoretical details of the quantum internet both entertaining and accessible.

Continue reading “‘Schrödinger’s Web’ offers a sneak peek at the quantum internet” »

Not too much here, but longevity research fans might like.

Time may be our worst enemy, and aging its most powerful weapon. Our hair turns gray, our strength wanes, and a slew of age-related diseases represent what is happening at the cellular and molecular levels. Aging affects all the cells in our body’s different tissues, and understanding its impact would be of great value in fighting this eternal enemy of all ephemeral life forms.

The key is to first observe and measure. In a paper published in Cell Reports, scientists led by Johan Auwerx at EPFL started by asking a simple question: how do the tissues of aging mice differ from those of mice that are mere adults?

Continue reading “Understanding the effect of aging on the genome” »

Stopping the cannibalistic behavior of a well-studied enzyme could be the key to new drugs to fight age-related diseases, according to a new study published online in Nature Cell Biology. For the first time, researchers in the Perelman School of Medicine at the University of Pennsylvania show how the self-eating cellular process known as autophagy is causing the SIRT1 enzyme, long known to play a role in longevity, to degrade over time in cells and tissue in mice. Identifying an enzymatic target is an important step that may lead to new or modified existing therapeutics.

“Blocking this pathway could be another potential approach to restore the level of SIRT1 in patients to help treat or prevent age-related organ and immune system decline,” said first author Lu Wang, Ph.D., a postdoctoral researcher in the lab of Shelly Berger, Ph.D., a professor of Cell and Developmental Biology in the Perelman School of Medicine and a professor of Biology in the School of Arts and Sciences at Penn. Berger also serves as senior author on the paper.

“The findings may be of most interest to the immune aging field, as autophagy’s role in SIRT1 in immune cells is a concept that hasn’t been shown before,” Wang added. “Exploiting this mechanism presents us with a new possibility of restoring immune function.”

A newly identified genetic factor allows adult skin to repair itself like the skin of a newborn babe. The discovery by Washington State University researchers has implications for better skin wound treatment as well as preventing some of the aging process in skin.

In a study, published in the journal eLife on Sept. 29, the researchers identified a factor that acts like a molecular switch in the skin of baby mice that controls the formation of hair follicles as they develop during the first week of life. The switch is mostly turned off after skin forms and remains off in adult tissue. When it was activated in specialized cells in adult mice, their skin was able to heal wounds without scarring. The reformed skin even included fur and could make goose bumps, an ability that is lost in adult human scars.

“We were able to take the innate ability of young, neonatal skin to regenerate and transfer that ability to old skin,” said Driskell, an assistant professor in WSU’s School of Molecular Biosciences. “We have shown in principle that this kind of regeneration is possible.”

Additionally, some reports have suggested that then-President Woodrow Wilson downplayed the virus, but that is a “wrong and a false trope of popular history,” Markel said. Wilson, who would later contract the virus, was organizing and commanding the U.S. effort in World War I and once the war ended, he sailed for Paris, where he stayed until April of 1919 organizing a peace treaty and the League of Nations, Markel said.

“The federal government played a very small role in American public health during that era. It was primarily a city and state role and those agencies were hardly downplaying it,” he said.

Unlike today, there was no CDC or national public health department. The Food and Drug Administration existed but consisted of a very small group of men. Additionally, there were no antibiotics, intensive care units, ventilators, IV fluids or vaccines. “You got a bed or maybe nursing care,” Markel said.

From the Science of Beer to learning about the benefits of GMOs; Saskatchewan is celebrating science with exciting online events and activities that showcase the province’s bioscience sector. Ag-West Bio, Saskatchewan’s bioscience industry association, coordinates events with the help of a local committee.

Ag-West Bio President and CEO Karen Churchill says amid the COVID-19 pandemic, biotechnology is in the spotlight. “Saskatchewan organizations in our research cluster have joined the global effort to develop vaccines as well as preventative and treatment solutions to deal with the virus. As a community, we should take note of the achievements of our local scientists and companies. Global Biotech Week gives us an opportunity to give them a (virtual) pat on the back!”

The Government of Saskatchewan and the Cities of Regina and Saskatoon have proclaimed September 28 to October 4 as Global Biotech Week.

Frost & Sullivan’s recent analysis, Data Science Impacting the Pharmaceutical Industry, finds that data science tools are promising technologies transforming drug discovery costs, speed, and efficiency. When combined with other emerging tech areas, artificial intelligence (AI) technologies move…

Pharmaceutical companies and hospitals are adopting data science rapidly, and its application is going to be established in all branches of healthcare

SANTA CLARA, Calif., Sept. 29, 2020 /PRNewswire/ — Frost & Sullivan’s recent analysis, Data Science Impacting the Pharmaceutical Industry, finds that data science tools are promising technologies transforming drug discovery costs, speed, and efficiency. When combined with other emerging tech areas, artificial intelligence (AI) technologies move to the next phase of advancements. Hence, they are expected to witness adoption by pharma and biotech companies in the next four to five years. Further, with the COVID-19 pandemic, AI and machine learning (ML) can be used for drug research and clinical trials against the coronavirus to screen large databases and perform docking studies to identify existing potential drugs or design new drugs using advanced learning algorithms.

Continue reading “Data Science to Accelerate Drug Discovery with Artificial Intelligence and Machine Learning, Says Frost & Sullivan” »

Activities will include experiments, live Q&A with scientists, demonstrations, performances, podcasts, behind-the-scenes tours and more — along with up-to-the-minute information on what researchers are learning about COVID-19.

WOODS HOLE, Mass. — The dialogue between neurons is of critical importance for all nervous system activities, from breathing to sensing, thinking to running. Yet neuronal communication is so fast, and at such a small scale, that it is exceedingly difficult to explain precisely how it occurs. A preliminary observation in the Neurobiology course at the Marine Biological Laboratory (MBL), enabled by a custom imaging system, has led to a clear understanding of how neurons communicate with each other by modulating the “tone” of their signal, which previously had eluded the field. The report, led by Grant F. Kusick and Shigeki Watanabe of Johns Hopkins University School of Medicine, is published this week in Nature Neuroscience.

In 2016 Watanabe, then on the Neurobiology course faculty, introduced students to the debate over how many synaptic vesicles can fuse in response to one action potential (see this 2-minute video for a quick brush-up on neurotransmission). To probe this controversy, they used a “zap-and-freeze” imaging technology conceived by co-authors M. Wayne Davis, Watanabe and Erik Jorgensen, and built by Leica for testing in the Neurobiology course. They zapped a neuron with electricity to induce an action potential, then quickly froze the neuron and took an image. They saw multiple vesicles fusing at once at many synapses, the first novel finding of this Nature Neuroscience report.

Continue reading “Tone of voice matters in neuronal communication” »